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Background: Interstitial deletions of chromosome 11 long arm are rarely observed and the associated phenotype
ranges from normal to severe, depending on the position and size of the deletion and on the presence of unmasked
recessive genes on the normal homologous. To our knowledge 32 cases are reported in literature with three family
cases. Phenotype-genotype correlation is not very clear and the most common features are characteristic facial
dysmorphisms, palate anomalies and developmental delay. Growth retardation is not typical and other major
malformations are reported in some cases.
Case Presentation: We described a child with 11q interstitial deletion diagnosed at birth with hypotonia and minor
dysmorphisms using standard cytogenetic techniques; array CGH was subsequently performed to define the deletion
at a molecular level.
Conclusions: This case gave us the opportunity to attempt a genotype-phenotype correlation reviewing the
literature and to describe a rehabilitative program that improved the development perspectives of this child.
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Terminal 11q deletions are reported in literature to be
associated with the well-described Jacobsen Syndrome.
On the contrary interstitial deletions are very uncom-
mon and heterogeneous in size and location of break-
points, spanning from bands 11q13 to 11q23. From the
first description by Taillemite et al. [1], 31 more cases were
described [2-21], case ID 4366 in the European Cytogene-
tists Association Register of Unbalanced Chromosome
Aberration, ECARUCA (www.ecaruca.net), case ID 3945
ECARUCA. Only in seven reports the deletion was charac-
terized by cytogenetic molecular techniques [2-8]. The ma-
jority of deletions are de novo, but three family cases are
described with normal or borderline phenotype [2,4,7].* Correspondence: renata.nacinovich@unimib.it
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distribution, and reproduction in any mediumPosition and size of deletions are heterogeneous. The
definition of the breakpoints of an interstitial 11q de-
letion by conventional techniques is difficult because
the banding pattern could be confusing, but new mo-
lecular methods such as array CGH and SNPs allow
an optimal definition of the breakpoint regions. Clin-
ical phenotype includes several dysmorphic features,
palate anomalies and developmental delay. Growth re-
tardation, hypotonia, seizures, congenital heart malfor-
mation, kidney and skeletal anomalies are associated
features in some cases.
Here we describe a case of de novo interstitial deletion of
chromosome 11 long arm identified at birth while investi-
gating mild dysmorphisms and hypotonia. The long term
rehabilitative program is described and the good results
obtained allow us to be positive in the prognosis of similar
cases of 11q interstitial deletions. Finally we attempt a
genotype/phenotype correlation reviewing the literature to
search candidate genes with a role in the phenotype.tral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited.
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The proband is a boy and he is the only child born from
a 36 year old father and a 27 year old mother. The par-
ents were healthy and unrelated; paternal family history
was negative for genetic diseases, while in the maternal
family, eight members were affected by retinitis pigment-
osa with an autosomal dominant pattern of transmission.
Prenatal ultrasonographic evaluation gave normal results
in fetal growth and morphology. No prenatal invasive
genetic test was performed.
The child was born by natural delivery after a 40 week
gestation plus 5 days. Birth weight was 3420 g (25°- 50°
centile for gestational age), length at birth was 52 cm,
(between 50°- 75° centile), occipito-frontal circumference
(OCF) was 35.5 cm (50°- 75° centile), APGAR score was
9/10. In neonatal period, the child presented hyperpy-
rexia (blood, urine and cerebrospinal fluid microbio-
logical analyses were all negative) and greater than 10%
weight loss, which regressed with adequate nutrition.
Episodes of bronchospasm and tirage, repeated episodes
of cyanosis and desaturation resolved spontaneously
shortly before discharge (at one month of age). During
childhood his height growth was at the lower limit. He
did not show any major malformation, besides submu-
cous cleft palate. Brain MRI scan did not show any
structural anomalies.
He had mild myopia and his hearing was normal. He
did not show any significant medical complications.
At the age of 12 years and 1 month his weight was
41.6 kg (25°-50° percentile), his height was 134.2 cm
(<3° percentile) and his OFC was 53 cm (50° percentile).
His Body Mass Index (BMI) was 23 (75°-90° percentile).
Facial dysmorphic features included long face, high nasal
bridge, short and smooth philtrum, micrognathia. He had
small hands and nasal speech.
Endocrinological analysis (IGF-1 dosage and growth
hormone stimulation test with arginine) showed results
consistent with isolated growth hormone (GH) defi-
ciency. A further brain MRI scan, carried out when he
was twelve, revealed a small pituitary gland. GH treat-
ment has been advised and the patient has just started
this therapy.
Written informed consent was obtained from the par-
ents for publication of this case report and any accom-
panying images.
At birth, karyotype on peripheral blood lymphocytes
was requested because of mild hypotonia and minor dys-
morphic features.
Conventional cytogenetic analysis revealed an intersti-
tial deletion on chromosome 11 from bands 11q13.5 to
11q21 (Figure 1A). The parents’ karyotypes were both
normal and the analysis was extended to 100 metaphases
to rule out 11q deletion mosaicism. At the age of twelve,
a comparative genomic hybridization array (Array-CGH)was performed using a CGH+ SNP 4 × 180 K microarray
kit (Agilent Technologies). The microarray contained
110,172 probes with a median probe spacing of 25.3 Kb
(5 KB in International Standards for Cytogenomic Arrays
Consortium, ISCA) and 59,647 SNP (UCSC hg19, http://
genome.ucsc.edu/). Array-CGH was performed according
to the manufacturer’s instructions (Agilent Technologies)
and allowed the identification of a more distal deletion
of 17,2 Mb in size: from 11q14.3 to 11q22.3 (from nt
92,434,272 to nt 109,584,301)(555 probes with median
Log2ratio value of −1.04). In the same region, 337 SNP
probes showed a single allele (Figure 1B,C). No add-
itional pathogenetic Copy Number Variations (CNVs)
were detected. The molecular karyotype, defined following
the International System of Chromosome Nomenclature
2013, was: arr 11q14.3q22.3(92,434,272-109,584,301)x1.
At 1 month of age, the proband’s neurological examin-
ation showed no major dysfunctions; clinical observation
according to Prechtl´s Method on the Qualitative As-
sessment of General Movements [22] showed a pattern
characterized by Poor Repertoire. His motor milestones
were not significantly delayed: control of the head at
4 months, sitting without support at 8 months, hands
and knees crawling at 11 months, standing with assist-
ance at 13 months, walking alone at 24 months.
Parents reported vocalization, babbling and the first
word “mamma” being uttered at one year of age. “Mamma”
remained the only word used to name everything word
until 19 months of age. After a period of hospitalization
following an accidental fall which caused clavicle fracture
and a second spell in hospital due to gastroenteritis, the
child presented an arrest in speech and psychomotor com-
petencies. These aspects were inscribed in a global regres-
sion of communicational and relational capacities.
Speech development between 20 and 36 months was
characterized by: aphonia, amimia, pseudo- articulatory
movements, reduced opening of the labial rima. Moreover,
the child showed a poor communicative intent even at a
non verbal level.
At 3 years he was a clumsy, passive and withdrawn
child, not interested in playing. Therefore, at 3 years of
age a psychomotor treatment with attention to relational
aspects was introduced twice a week.
During the first year of rehabilitation, the proband re-
duced his more passive traits becoming more and more
purposeful, actively responsive and assertive. Communi-
cative intention emerged together with the increasing
awareness of his speech difficulties.
There was a large discrepancy between the verbal com-
prehension (discrete) and expressive skills: he used ges-
tures associated with vocalization to indicate, to formulate
questions, to express disappointment or excitement. Then,
speech therapy sessions began twice a week at the age
of 4.
Figure 1 Cytogenetic, arrayCGH and WISC-III results. (A) QFQ and GTG banded chromosome 11 homologues. The deleted chromosome 11 is
on the right. (B) Array-CGH analysis showing 17.2 Mb deletion (Log2ratio: −1.04) at 11q14.3q22.3 (nt 92434272–109584301; hg19, NCBI build 37)
(light blue bar) and loss of heterozygosity with 337 single alleles SNP. (C) enlargement of the deleted region (CytoGenomics software Agilent).
(D): WISC-III results: Verbal(VIQ), Performance (PIQ) and Total IQ (TIQ) at 9.11 ys and after 2 years of rehabilitation and counselling to parents and
teachers as regard as learning abilities.
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phonetic phonation. Later, rhinolalia and rhinophonia,
and a deficit in coordination and in phonological mem-
ory were observed. Consequently, a double diagnosis of
specific expressive language disorder and of childhood
apraxia of speech was formulated.
At 5 years, after one year of speech therapy, he
achieved a quite complete phonetic repertoire, vocabu-
lary increase with risk threshold for semantic errors, and
emerging narrative skills. While he showed an adequate
lexical comprehension, morphosyntactic comprehension
was delayed of one year and communication was sup-
ported by mimics and gestures. At the same time, he
developed social skills, showing more relational and
playing capacities with peers and adults.
At age 6, verbal speech was sufficiently intelligible
despite the persistence of hypotonic and uncoordinated
glosso-velo-pharyngeal muscles.
His cognitive development, as measured by WIPPSI
Scale, was in the lower limits of the normal range, with
a discrepancy between verbal (VIQ) and performance
(PIQ) scores (VIQ =85; PIQ =96; Full Scale IQ = 89) [23].
At the age of 8, the proband presented an impairment in
the ability of naming objects and in lexical retrieval with
the help of phonemic cues. On using the Italian version of
the Peabody Picture Vocabulary Test [24], comprehension
was almost adequate (Language quotient = 82).Morphosyntactic comprehension using the Rustioni
Metz test [25] showed a delay of about 2 years. The ver-
bal short term memory span was 3 (inadequate).
Moreover, learning difficulties in the presence of a
cognitive development at the lower limit of the normal
range emerged. In particular, reading comprehension,
measured using the MT battery of tests [26], was inad-
equate (correct answers: 6/10), in the absence of dyslexia
and dysorthography, as measured with the Dyslexia and
Orthographic coding test [27]. Therefore, the logopedic
rehabilitation continued until the child was 9 years old,
with the aim to improve oral and written language com-
prehension. In the meantime, his writing and reading
abilities supported him in planning the phonological
string in speech.
Afterwards, counselling to parents and teachers, to-
gether with neuropsychiatric follow up continued until
today with longitudinal controls (twelve years). We con-
sidered highly important to support parents and teachers
in finding a harmonious global development which
could take into account not only the educational aspects,
but also the emotional and relational sides.
We were able to observe a global improvement in cog-
nitive abilities (as illustrated in Figure 1D, where WISC
III at 9 and 11 years of age are compared) [28].
Currently the child shows good skills at school in the
application of the learned mechanisms, but he has more
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are required. However, he is able to evaluate his work
and adopt compensatory strategies in order to overcome
his difficulties. He is competitive with his schoolmates,
comparing their tests results and scores. He shows a
good personal and social independence and participates
in curricular and extracurricular activities with peers.
Conclusions
Interstitial 11q deletions are rare with only 32 pa-
tients described in literature to our knowledge [1-21]
(Additional file 1: Table S1) they span from bands 11q13
to 11q23, but the majority of them has not been character-
ized with a molecular approach. A map was drawn up, in
which deletions were positioned on the 11q chromosome
ideogram (550 band resolution level) on the basis of the
deletion sizes (from the largest to the smallest). When
breakpoints were defined with a low resolution level (i.e.
11q13), we assumed the breakpoint to be in the middle
(11q13.2). We disregarded two cases because of uncertain
breakpoints [9,15]. We report some frequent clinical signs
selected from Table 1. Heterogeneity in position and size
is evident and a minimal common deleted region could
not be identified (Figure 2). Moreover, cases with a
molecularly-defined deletion (Figure 2, light blue bar) are
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Minor skeletal anomdifferent in size a genotype/phenotype correl cannot be
assessed. The first observation is that moderate/severe de-
velopmental delay correlates with the deletion size: in fact
it was only reported in patients with larger loss, whereas
growth retardation is distributed in the entire region.
Growth is likely to be influenced by many factors, both
genetic and environmental; it is therefore difficult to iden-
tify a close relationship with the deletion itself. Palate
anomalies and seizures seem to correlate with more distal
deletions (11q22-q23), while kidney/genital anomalies and
cardiac malformations are reported in both proximal
(11q13q21) and in distal ones (11q21q23.3) and don’t
seem to correlate with the deletion size. The two families
reported by Goumy et al. [2] and Li et al. [4] (Additional
file 1: Table S1) with phenotypically normal deletion car-
riers are very interesting. Goumy et al. [2] describe a
morphologically normal female fetus that inherited a
11q14.3q21.1 deletion from the mother whose clinical fea-
tures were toe camptodactyly and ophtalmologic disorders.
Her phenotypically normal maternal grandfather carried
the same deletion. Prenatal diagnosis was carried out
because of a positive Down Syndrome maternal serum
screening. Li et al. [4] reported a 6 year old boy with mild
intellectual impairment, short stature and a 11q14.3q21
deletion. Family study showed four males through three
generations with the same deletion and apparently normalw of 32 cases and present case
alies Present case Medical complications Present case
ead 4 - Hypotonia 7 -
2 - Strabism 3 -
lids 6 - Myopia 2 +
bral 7 - Seizures 6 -
ss 3 -
s 6 - Others
9 - Microcephaly 3 -
s 13 - Growth retardation 9 +
s 12 + Developmental delay 19 +
4 - Hyperactive behavior 3 -




Figure 2 Deletions map with major clinical signs reported as coloured dots. Chromosome 11q arm ideogram with on the left gene density
(from Ensemble http://www.ensembl.org/index.html) and, on the right, vertical bars are deletions reported in literature from the largest to the
smallest. Red bar PC: present case. Green bars: family cases. Light blue bars: cases with molecularly defined deletions (13a and 13 b are family cases).
The numbers above the bars correspond to those reported in Additional file 1: Table S1. Specific clinical signs are reported as coloured dots.
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between chromosomal anomaly and proband phenotype.
In both reports, FISH with BAC clones was performed in
order to partially define deletion breakpoints: Li identi-
fied a 3.6 Mb deletion (from rp11-792 M23 to rp11-
573 M3) while Goumy defined the lowest deleted size of
8.5 Mb [from rp11-372E19 (91,733 Mb) to rp11-775E2
(100,424 Mb)]. These regions range approximately from
nucleotide 89,255,000 (11q14.3) to 100,424,000 (11q22.1).
Sparkes et al. [7] (Additional file 1: Table S1) described the
third familial case: a male fetus tested for ultrasound mul-
tiple anomalies (choroid plexus cysts, echogenic intracar-
diac foci, a suspected structural cardiac malformation, left
club foot and small cerebellum) with a maternally inherited
11q14.3q22.3 deletion. The mother was of normal intellect
and healthy, but she had a surgically repaired bilateral club
foot and high myopia. Moreover a cerebral MRI in the
mother showed multifocal white matter changes and mild
cerebral atrophy. Array CGH evidenced a 17,3 Mb deletion
(from nt 89,492,818 to nt 106,832,040) and a 0,9 Mb dupli-
cation (from nt 88,258,744 to nt 89,103,489) in 11q21q23.
From a molecular point of view, this case partially overlapswith our case (17,2 Mb deletion from nt 92,434,372 to nt
109,584,30), but we could not find any common clinical
features: the case we are presenting showed mild develop-
mental delay and submucous cleft palate; a cerebral MRI
scan did not evidence any atrophy and he did not suffer
from club foot.
In the deleted region of our patient, about 94 genes
are mapped [http://genome.ucsc.edu/]: 53 of them have
known functions, some of them being associated with auto-
somal recessive disease, others have no OMIM phenotype.
A biological role is still unkwnown for the other 41 genes.
Eight OMIM genes are expressed in the brain (FAT 3,
MED17, PANX1, GPR83, CNTN5, KIAA1377,GRIA4
and GUCY1A2). The CNTN5 gene, coding for contac-
tins which mediate cell surface interactions in the devel-
opment of the nervous system, is described as been
involved in autism spectrum disorders [29]. The GRIA4
gene belongs to the glutammate receptor family that
plays an important role in excitatory synaptic transmis-
sion. Patients with mental retardation and multiple con-
genital abnormalities showed a significant copy number
change in the glutammate receptor family [30]. Even if it
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a specific gene, we may hypothesize the role of haploin-
sufficiency of these two genes in the patient phenotype.
In literature [8,10,12,16,20] a psychomotor delay and a
language disorder were described, in a few cases, as an
expressive disorder. Our patient also showed the par-
ticular trait of a childhood apraxia of speech.
The phenotype we observed in our case has only been
described in one other report [11] in which the proband
shows poor eye contact and low interest in his surround-
ing. The rehabilitation process proposed and the neuro-
psychiatric follow up and counselling have allowed the
recovery of adequate relational competences, improved
speech and language abilities and a positive evolution of
his global cognitive and adaptive capacities and social
and school skills.
After considering all the collected clinical information,
we drew the conclusion that it is not possible to define a
distinctive phenotype of the 11q partial monosomy due
to the heterogeneity in size and position of the deletions
and to the absence of a minimal common deleted region.
About family cases showing normal phenotype [2,4] we
could hypothesize the effect of modifier genes or a com-
pensatory gene expression of the allele on the normal
chromosome 11. More literature data and a better molecu-
lar characterization are needed to confirm this hypothesis.
Moreover, the phenotype is not only due to haploinsuffi-
cient genes but it is the result of complex gene – gene and
gene-environment interactions.
We found this case particularly interesting because it
gave us the opportunity to describe a rehabilitation pro-
gram that we believe has improved the development per-
spectives of this child and therefore his quality of life.
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